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A tripeptide-like prolinamide-thiourea catalyst with (S)-proline, (1S,2S)-diphenylethylenediamine and
(S)-di-tert-butyl aspartate as building blocks provides the products of the reaction between ketones and
aromatic aldehydes in high to quantitative yields and high stereoselectivities (up to 99 : 1 dr and 99% ee).
Both the chiral centers of the diamine unit are essential, while the thiourea hydrogen originating from
the amine and the amide hydrogen play a predominant role for the catalyst efﬁciency.
Introduction
The majority of organocatalysts developed up to now for
asymmetric organic transformations1 employ more than one
functionality in the catalytic mechanism that acts through either
covalent or non-covalent interactions.2,3 The asymmetric aldol
reaction is a powerful method for the construction of carbon–
carbon bonds in an enantioselective fashion.4,5 The most impor-
tant improvement in the ﬁeld of organocatalysed aldol reaction
has been the development of catalysts combining the prolin-
amide unit with functionalities able to act as hydrogen bond
donors. Representative examples of such prolinamides that
efﬁciently catalyze asymmetric aldol reactions are shown in
Fig. 1 (compounds 1–5).6–10
Recently, we have presented catalyst 6 based on (S)-proline
and (1S,2S)-diphenylethylenediamine, which provided the pro-
ducts of the reactions between ketones and aromatic aldehydes
in high to quantitative yields and with high stereoselectivities.11
Amide 6 bearing a thiourea group was designed based on the
assumption that the pyrrolidine group would activate the nucleo-
phile, while both the amide group and the thiourea functionality
would activate the electrophile through hydrogen bonding.11
However, there is no experimental evidence about which of the
amide hydrogen or the thiourea hydrogens is really involved in
the formation of hydrogen bonds. A study on the structural
requirements of the prolinamide-thiourea was undertaken in
order to achieve optimum reactivity.
Results and discussion
In the present manuscript, our aim was to clarify the importance
of the presence of: (a) a new chiral center in the amine of the
thiourea, (b) the stereogenic centers of the diamine unit, (c) a
thioamide instead of an amide bond, (d) an additional proline
residue and (e) the hydrogen bond donors of the catalyst (amide
hydrogen and hydrogen atoms of the thiourea group). At the
beginning, the aromatic moiety of the thiourea was substituted
by the chiral bulky unit of a tert-butyl ester of an α-amino acid
(catalysts 7 and 8, Fig. 2). The chiral bulky group is expected
to help on placing the electrophile on the appropriate orien-
tation, thus determining the face of the electrophile attack.
Fig. 1 Some known prolinamide catalysts.
†This article is part of the joint ChemComm–Organic & Biomolecular
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Simultaneously, it would efﬁciently block the back face of
the transition intermediate. Starting from commercially available
Fmoc-L-proline and utilizing either tert-butyl phenylglycinate
or di-tert-butyl aspartate,12 catalysts 7 and 8 were synthesized
(for full experimental procedures for the synthesis of the
catalysts utilized, see ESI‡).
The stereochemistry of the phenyl moieties on the chiral
diamine backbone was postulated to play a crucial role on the
conformation adopted by the catalyst. In an optimum scenario,
these moieties should bring the thiourea moiety in close prox-
imity to the area where the electrophile is placed in the transition
intermediate. To assess the role of the chiral backbone of the
diamine in the reactivity of the catalyst, compounds 9 and 10
were synthesized (Fig. 2). Since a number of catalysts exist in
the literature bearing thioamide functionalitilies,10,13 catalyst 11
was next synthesized employing Lawesson’s reagent to introduce
the sulfur of the thioamide (Fig. 2). Moreover, a number of
peptide catalysts have emerged as efﬁcient organocatalysts for
organic transformations,14 thus, the peptide-like catalyst 12 was
prepared to be evaluated (Fig. 2).
The reaction of acetone with 4-nitrobenzaldehyde is a usual
model reaction to study the efﬁcacy of new organocatalysts. At
the beginning, the catalytic activity of all catalysts that were
synthesized was evaluated under our previous optimized reaction
conditions utilizing toluene as a solvent at −20 °C for 24 hours
(Table 1). From our previous studies, we had already showed
that prolinamides bearing (1S,2S)-diphenylethylenediamine
instead of (1R,2R)-diphenylethylenediamine, led to better results
indicating that the conformation of the catalyst is extremely
important for high catalytic activity (entry 1 vs. entry 2,
Table 1).11 The catalysts based on tert-butyl phenylglycinate (7)
led to similar results, while the one based on di-tert-butyl
aspartate provided the product in quantitative yield and excellent
enantioselectivity (99% ee) (entries 3 and 4, Table 1). The steric
hindrance provided by the side chain bulky tert-butyl ester of
aspartic acid could be the reason for the slight increase on the
enantioselectivity. The bulkiness provides additional blocking
of the back face and also control the face of the attack of the
electrophile by pushing the aryl moiety away from it. In order
to shed light on whether the chiral backbone of the diphenyl-
ethylene diamine played any role in the catalytic activity,
catalysts 9 and 10 were evaluated. As shown in entries 5 and 6
of Table 1, a phenyl group on both chiral centers is required
otherwise the enantioselectivity is considerably lower. It seems
that both phenyl groups are necessary to the current chirality in
order for the catalyst to adopt the appropriate conformation for
high catalytic activity. When one of the chiral centers and the
phenyl moiety is missing a different conformation is adopted
which leads to diminished catalytic activity. The use of thioa-
mide 11 led to similar results as those obtained with catalyst 8
(entry 7, Table 1). Thus, subtle changes in the hydrogen bonding
power of the prolinamide unit provide alterations in the catalytic
activity, showing that this amide bond is most likely taking part
in inﬂuencing the outcome of the reaction. Peptide-like catalyst
12 led to far inferior results, thus leading to the conclusion that
adding a prolyl unit in the catalyst does not lead to the appropri-
ate conformation for high reactivity being adopted (entry 8,
Table 1). We assume that moving the pyrrolidine nitrogen
and the hydrogen bonding sites of the catalyst further apart
(changing the optimum distance), as well as the lack of the
α-amide in relation to the free pyrrolidine nitrogen are the key
reasons for this deterioration in both reactivity and selectivity.
From Table 1, it is quite obvious that the prolinamide unit and
the (1S,2S)-diphenylethylenediamine chiral moiety, as well as
the thiourea moiety are required for high catalytic activity. More-
over, when the aromatic moiety on the thiourea is replaced by a
bulky chiral group such as di-tert-butyl aspartate, better results
are obtained. To elucidate the role of each of the potential
hydrogen bonding sites, derivative 13, where the amide bond
was replaced by an ester bond, and derivative 14, where the
thiourea hydrogen originating from the diamine residue was
Fig. 2 Catalysts 7–12 employed in this study.
Table 1 Direct asymmetric aldol reaction between acetone and
4-nitrobezaldehyde using various catalysts
Entry Catalyst Yielda (%) eeb (%)
1 611 95 97
2 6 (R,R)11 70 82
3 7 96 96
4 8 100 99
5 9 97 58
6 10 70 4
7 11 100 97
8 12 53 5
a Isolated yield. b The enantiomeric excess (ee) was determined by chiral
HPLC. 4-NBA: 4-nitrobenzoic acid.
5614 | Org. Biomol. Chem., 2012, 10, 5613–5619 This journal is © The Royal Society of Chemistry 2012
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replaced by an oxygen atom, were synthesized (Fig. 3, for the
synthesis see the ESI‡). In addition, derivatives 15 and 16 were
also synthesized. The results of the catalytic activity of these
derivatives are summarized in Table 2. Derivative 13 provided
the product in high yield and moderate ee (entry 3 vs. entry 2,
Table 2) clearly demonstrating the involvement of the amide
hydrogen in the transition state. When the aromatic part of the
thiourea is just a phenyl group, the catalytic results are similar to
those observed with catalyst 6 (entry 5 vs. entry 1, Table 2).
However, a dramatic loss of the enantioselectivity was observed,
when the NH of the thiourea was replaced by NMe (entry 6 vs.
entries 1 and 5, Table 2). The low ee (29%) highlights the impor-
tance of that NH for the outcome of the reaction. Finally, the
replacement of the NH by O in derivative 14, led to mediocre
enantioselectivity (entry 4 vs. entry 1, Table 2). Taken together,
the importance of the hydrogen bond donors of the catalyst
follows the order: thiourea hydrogen originating from the amine
> amide hydrogen > thiourea hydrogen originating from the
diamine.
We then turned our attention to the direct comparison of the
new catalyst 8 with catalyst 6 (Table 3). Although the catalyst
based on aspartic acid leads to quantitative yield at room temp-
erature, the enantioselectivity is quite low compared with the
results obtained with catalyst 6 (entry 1 vs. entry 2, Table 3).
However, when the temperature is decreased to 0 °C, both cata-
lysts behave similarly (entry 3 vs. entry 4, Table 3). Decreasing
the temperature even more and going to optimum catalyst con-
ditions, the results are reversed and now catalyst 8 based on
aspartic acid leads to quantitative yield and almost complete
stereocontrol, outperforming catalyst 6 (entry 5 vs. entry 6,
Table 3). Thus, it is obvious that the enantioselectivity induced
by catalyst 8 is highly dependent on temperature, while in the
case of catalyst 6, there is a dependence but not to the
same extent. When the catalyst loading was decreased down to
5 mol%, catalyst 8 continued to provide the desired product in
almost quantitative yield and excellent enantioselectivity, while
catalyst 6 led to inferior results (entry 7 vs. entry 8, Table 3).
In both cases, prolonged reaction time was needed. Trying to
identify the limits of both catalysts, the catalyst loading was
dropped to 2 mol%. Still the catalyst based on aspartic acid was
slightly better (entry 9 vs. entry 10, Table 3). Finally, when
the reaction was performed at −40 °C, catalyst 8 outperformed
catalyst 6 (entry 11 vs. entry 12, Table 3).
Having established catalyst 8 as the optimum catalyst, the
scope and limitations were sought and the results are shown
in Table 4. The reaction of acetone with aromatic aldehydes
bearing electron-withdrawing groups led to excellent yields
(82–100%) and high enantioselectivities (96–99%) (entries 1–4,
Table 4). However, benzaldehyde produced the product in mod-
erate yield, although in high enantioselectivity (entry 5, Table 4).
Cyclic ketones such as cyclohexanone are well tolerated as well
(entries 6–10, Table 4). When electron-withdrawing groups
existed on the aromatic ring, the products were obtained in
excellent yields, high diastereoselectivity and enantioselectivity.
While the use of 4-bromobenzaldehyde or benzaldehyde led to
diminished yields but the diastereocontrol and enantiocontrol
Table 2 Direct asymmetric aldol reaction between acetone and
4-nitrobezaldehyde using various catalysts
Entry Catalyst Yielda (%) eeb (%)
1 6 95 97
2 8 100 99
3c 13 92 48
4c 14 79 70
5c 15 100 98
6c 16 98 29
a Isolated yield. b The enantiomeric excess (ee) was determined by chiral
HPLC. cReaction time: 48. 4-NBA: 4-nitrobenzoic acid.
Fig. 3 New catalysts 13–16 to probe the necessity of each hydrogen
bond.
Table 3 Comparison of catalysts 6 and 8 on the direct asymmetric
aldol reaction between acetone and 4-nitrobenzaldehydea
Entry
Catalyst,
loading (mol%) Time (h) Temp. (°C) Yielda (%) eeb (%)
1 8, 10 24 r.t. 100 63
2 6, 10 24 r.t. 98 87
3 8, 10 24 0 96 93
4 6, 10 24 0 94 94
5 8, 10 24 −20 100 99
6 6, 10 24 −20 95 97
7 8, 5 48 −20 98 98
8 6, 5 48 −20 90 97
9 8, 2 48 −20 63 98
10 6, 2 48 −20 58 97
11 8, 5 48 −40 77 99
12 6, 5 48 −40 46 98
a Isolated yield. b The enantiomeric excess (ee) was determined by chiral
HPLC.
This journal is © The Royal Society of Chemistry 2012 Org. Biomol. Chem., 2012, 10, 5613–5619 | 5615
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remained high. When cyclopentanone was utilized, a reverse in
the diastereocontrol was observed. In most cases, the reaction
occurred with high anti stereoselectivity, however, in the case
of cyclopentanone, the syn product was the predominant
diastereomer (entry 11, Table 4). A number of cyclic ketones
reacted with 4-nitrobenzaldehyde providing the products in
varying yields (66–99%), high diastereoselectivities (96 : 4 to
99 : 1)15 and excellent enantioselectivities (92–99% ee) (entries
12–14, Table 4). Finally, the desymmetrization of 4-substituted
cyclohexanones was found to be possible. When 4-methyl cyclo-
hexanone was utilized, quantitative yield was obtained along
with high stereo- and enantiocontrol (entry 15, Table 4).
Solid-supported catalysts present a number of advantages.16
Organocatalysts have been successfully employed in the syn-
thesis of solid-supported systems that present distinct catalytic
activities.17 Thus, we envisaged the incorporation of our catalyst
on a number of commercially available resins (Scheme 1). In
this study, JandaJel (JJ), polystyrene-divinylbenzene (PS-DVB)
and CM (ChemMatrix) resins were employed, coupled with
intermediate 17 and deprotection of the Fmoc group furnished
the desired solid-supported organocatalysts 19a–c. Unfortu-
nately, when the catalyst was anchored on the solid support, the
catalytic activity dropped signiﬁcantly (entries 1–7, Table 5).
Utilising the JandaJel (JJ) resin, low yield and diminished enan-
tioselectivity were observed, while performing the reaction at
room temperature or using higher catalyst loading did not
improve the catalytic activity (entries 1–3, Table 5). The
PS-DVB resin had similar reactivity both at low temperature and
room temperature (entries 4 and 5, Table 5). Finally, the use of
CM resin led to slightly improved yield but the enantioselectivity
Table 5 Direct asymmetric aldol reaction between acetone and
4-nitrobezaldehyde using various catalysts
Entry Catalyst Yielda (%) eeb (%)
1 19a 31 70
2c 19a 64 15
3c,d 19a 61 34
4 19b 35 68
5c 19b 54 38
6 19c 42 69
7c 19c 71 41
a Isolated yield. b The enantiomeric excess (ee) was determined by chiral
HPLC. c The reaction took place at room temperature. d 50 mol%
catalyst was employed. 4-NBA: 4-nitrobenzoic acid.
Scheme 1 Synthesis of catalysts 19a–c.
Table 4 Direct asymmetric aldol reaction between ketones and various
aldehydes using catalyst 8
Entry Ketone Ar Yielda (%) drb eec (%)
1 4-NO2C6H4 100 — 99
2 2-NO2C6H4 100 — 96
3 4-CF3C6H4 100 — 99
4 3-CNC6H4 82 — 99
5d C6H5 40 — 90
6 4-NO2C6H4 100 95 : 5 99
7d 3-NO2C6H4 95 93 : 7 97
8d 2-NO2C6H4 92 94 : 6 98
9d C6H5 57 >97 : 3 96
10d 4-BrC6H4 49 97 : 3 96
11 4-NO2C6H4 100 35 : 65 99
e
12d 4-NO2C6H4 98 96 : 4 97
13d –NO2C6H4 86 99 : 1 93
14d 4-NO2C6H4 66 96 : 4 92
15 4-NO2C6H4 99 93 : 7 99
a Isolated yield. b The diastereomeric ratio (dr) was determined by 1H
NMR spectroscopy and refers to the anti : syn ratio. c The enantiomeric
excess (ee) was determined by chiral HPLC. d The reaction time was 48.
e 86% ee for the anti, 99% ee for syn.
5616 | Org. Biomol. Chem., 2012, 10, 5613–5619 This journal is © The Royal Society of Chemistry 2012
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still remained mediocre (entry 6, Table 5). When the reaction
was performed at room temperature, the yield was increased in
the expense of the enantioselectivity (entry 7, Table 5).
From the above studies, we come to the conclusion that an
efﬁcient prolinamide-thiourea may have optimized activity for
the aldol reaction when it contains: (a) the (S)-prolinamide unit,
(b) the (1S,2S)-diphenylethylenediamine unit and (c) the thiourea
functionality involving the amino group of a chiral bulky amino
acid (preferably di-tert-butyl aspartate). It has to be noted that
we have reported that a primary amine thiourea consisting of
(1S,2S)-diphenylethylenediamine and (S)-di-tert-butyl aspartate
is a very efﬁcient catalyst for the Michael reaction.12a It is appar-
ent that by adding just one proline residue, we may convert this
catalyst to a new catalyst efﬁcient for the enantioselective aldol
reaction.
Conclusions
In conclusion, in this work we present our studies to understand
the structural features that a prolinamide-thiourea has to include
in order to catalyze the enantioselective aldol reaction. It has
been proven that both the chiral centers of the diamine unit
are essential, while the thiourea hydrogen originating from the
amine and the amide hydrogen play a predominant role in the
hydrogen bonding. These studies led to the tripeptide-like
catalyst 8 which effectively catalyzes this reaction. An appli-
cation of this improved organocatalyst has already been shown18
and its use in other asymmetric organic transformations is under
way.
Experimental section
General information
Organic solutions were concentrated under reduced pressure on a
Büchi rotary evaporator. Chromatographic puriﬁcation of pro-
ducts was accomplished using forced-ﬂow chromatography on
Merck Kieselgel 60 F254 230–400 mesh. Thin-layer chromato-
graphy (TLC) was performed on aluminum backed silica plates
(0.2 m, 60 F254). Visualization of the developed chromatogram
was performed by ﬂuorescence quenching using phospho-
molybdic acid, anisaldehyde or ninhydrin stains. Melting points
were determined on a Buchi 530 hot stage apparatus and are
uncorrected. 1H and 13C NMR spectra were recorded on Varian
Mercury (200 MHz or 50 MHz) and are internally referenced to
residual protio solvent signals (CDCl3). Data for
1H NMR are
reported as follows: chemical shift (δ ppm), integration, multi-
plicity (s = singlet, d = doublet, t = triplet, q = quadruplet,
m = multiplet, bs = broad signal, bs m = broad signal multiplet),
coupling constant and assignment. Wherever rotamers exist, are
presented in brankets. Data for 13C NMR are reported in terms
of chemical shift (δ ppm). Mass spectra were recorded on a
Finnigan Surveyor MSQ Plus, with only molecular ions and
major peaks being reported with intensities quoted as percen-
tages of the base peak. High performance liquid chromatography
(HPLC) was used to determine enantiomeric excesses and was
performed on a Agilent 1100 Series apparatus using Chiralpak®
AD-H, OD-H, AS-H and AD-RH columns. The conﬁguration of
the products has been assigned by comparison to literature data.
Optical rotations were measured on a Perkin Elmer 343 polari-
meter. Catalysts 6, 6 (R,R), 7 and 8 have been synthesized
following our previous protocols.11 For detailed synthetic pro-
cedures for the synthesis of the catalysts utilized in this study,
see the ESI.‡
(S)-tert-Butyl 2-{3-[(1S,2S)-1,2-diphenyl-2-[(S)-pyrrolidine-2-
carboxamido]ethyl]thioureido}-2-phenylacetate (7). Light
yellow solid; 0.11 g, 99% yield; mp 79–81 °C; [α]D = +24.7
(c = 1.0, CH3OH);
1H NMR (200 MHz, CD3OD) δ 7.47–6.98
(15H, m, ArH), 6.03–5.86 (2H, m, 2 × NCH), 5.19 (1H, d, J =
10.6 Hz, NCH), 3.79–3.21 (1H, m, NCH), 2.99–2.60 (2H, m,
NCH2), 1.95–1.43 (4H, m, 4 × CHH),1.30 [9H, s, C(CH3)3];
13C NMR (50 MHz, CD3OD) δ 184.2 (184.0) (CvS), 176.2
(176.6) (CO), 171.4 (171.7) (CO), 140.2 (Ar), 139.8 (Ar), 138.0
(Ar), 129.7 (Ar), 129.6 (Ar), 129.4 (Ar), 129.2 (Ar), 128.8 (Ar),
128.7 (Ar), 128.6 (Ar), 128.5 (Ar), 83.2 (82.8) [C(CH3)3], 63.6
(NCH), 62.7 (NCH), 61.4 (NCH), 60.1 (NCH), 46.6 (NCH2),
31.6 (CH2), 27.9 (28.1) [C(CH3)3], 26.5 (CH2); MS (ESI) 559
(M + H+, 100%); HRMS exact mass calculated for [M + H]+
(C32H39O3N4S) requires m/z 559.2737, found m/z 559.2733.
(S)-Di-tert-butyl 2-{3-[(1S,2S)-1,2-diphenyl-2-[(S)-pyrrolidine-
2-carboxamido]-ethyl]thioureido}succinate (8). White solid;
0.11 g, 99% yield; mp 89–91 °C; [α]D = +35.3 (c = 0.88,
CHCl3);
1H NMR (200 MHz, CDCl3) δ 8.56 (1H, d, J = 8.6 Hz,
NH), 8.05–7.87 (1H, br m, NH), 7.46–7.01 (10H, m, ArH),
6.92–6.66 (1H, br m, NH), 5.98–5.65 (1H, m, NCH), 5.33–5.06
(2H, m, 2 × NCH), 3.97–3.68 (1H, m, NCH), 3.09–2.76 (4H, m,
CH2CO2tBu, NCH2), 2.19–2.03 (1H, m, CHH), 1.87–1.55
(4H, m, 3 × CHH, NH), 1.43 [9H, s, C(CH3)3], 1.36 [9H, s, C
(CH3)3];
13C NMR (50 MHz, CDCl3) δ 182.6 (CvS), 170.4
(CO), 170.1 (CO), 169.9 (CO), 138.7 (Ar), 138.6 (Ar), 128.5
(Ar), 128.3 (Ar), 128.0 (Ar), 127.7 (Ar), 127.5 (Ar), 127.4 (Ar),
82.2 [C(CH3)3], 81.4 [C(CH3)3], 64.2 (NCH), 60.3 (NCH), 58.8
(NCH), 54.0 (NCH), 47.1 (NCH2), 37.8 (CH2CO2tBu), 30.5
(CH2), 28.0 [C(CH3)], 27.9 [C(CH3)], 25.8 (CH2); MS (ESI)
597 (M + H+, 100%); HRMS exact mass calculated for
[M + H]+ (C32H45O5N4S) requires m/z 597.3105, found m/z
597.3100.
(S)-Di-tert-butyl 2-{3-[(S)-1-phenyl-2-[(S)-pyrrolidine-2-carbox-
amido]ethyl]thioureido}succinate (9). Light yellow solid; 0.16 g,
92% yield; mp 52–54 °C; [α]D = −8.6 (c = 1.0, CHCl3); 1H
NMR (200 MHz, CDCl3) δ 8.27–7.99 (2H, m, 2 × NH),
7.43–7.08 (6H, m, ArH, NH), 5.29–5.09 (1H, m, NCH),
4.29–4.11 (1H, m, NCH), 3.93–3.34 (3H, m, NCH, 2 × NCHH),
3.00–2.72 (4H, m, CH2CO2tBu, NCH2), 2.11–1.51 (5H, m,
4 × CHH, NH), 1.33 [9H, s, C(CH3)3], 1.30 [9H, s, C(CH3)3];
13C NMR (50 MHz, CDCl3) δ 182.7 (CvS), 175.3 (CO), 170.1
(CO), 169.9 (CO), 139.1 (Ar), 128.3 (Ar), 127.3 (Ar), 126.5
(Ar), 81.7 [C(CH3)3], 80.9 [C(CH3)3], 60.0 (NCH), 58.2 (NCH),
57.9 (NCH), 53.8 (NCH2), 46.7 (NCH2), 37.6 (CH2CO2tBu),
30.3 (CH2), 27.8 [C(CH3)3], 27.7 [C(CH3)3], 25.4 (CH2); MS
(ESI) 521 (M + H+, 100%); HRMS exact mass calculated for
[M + H]+ (C26H41O5N4S) requires m/z 521.2792, found m/z
521.2783.
(S)-Di-tert-butyl 2-{3-[(S)-2-phenyl-2-[(S)-pyrrolidine-2-carbox-
amido]ethyl]thioureido}succinate (10). Yellow solid; 0.12 g,
This journal is © The Royal Society of Chemistry 2012 Org. Biomol. Chem., 2012, 10, 5613–5619 | 5617
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97% yield; mp 73–75 °C; [α]D = +19.4 (c = 1.0, CHCl3);
1H
NMR (200 MHz, CDCl3) δ 8.46–8.18 (1H, m, NH), 7.69–7.13
(7H, m, ArH, 2 × NH), 5.66–5.34 (1H, m, NCH), 4.49–3.58
(4H, m, NCH2, 2 × NCH), 3.23–2.52 (4H, m, CH2CO2tBu,
NCH2), 2.29–1.57 (5H, m, 4 × CHH, NH), 1.40 [18H, s, 2 × C
(CH3)3];
13C NMR (50 MHz, CDCl3) δ 183.6 (CvS), 175.2
(CO), 173.6 (CO), 169.2 (CO), 138.5 (Ar), 128.8 (Ar), 127.8
(Ar), 126.3 (Ar), 82.4 [C(CH3)3], 82.2 [C(CH3)3], 60.4 (NCH),
55.6 (NCH), 51.2 (NCH), 51.0 (NCH2), 46.9 (NCH2), 36.2
(CH2CO2tBu), 30.3 (CH2), 27.9 [C(CH3)3], 27.9 [C(CH3)3],
25.9 (CH2); MS (ESI) 521 (M + H
+, 100%); HRMS exact mass
calculated for [M + H]+ (C26H41O5N4S) requires m/z 521.2792,
found m/z 521.2782.
(S)-Di-tert-butyl 2-{3-[(1S,2S)-1,2-diphenyl-2-[(S)-pyrrolidine-
2-carbothioamido]-ethyl]thioureido}succinate (11). White solid;
0.04 g, 98% yield; mp 82–84 °C; [α]D = +21.4 (c = 1.0, CHCl3);
1H NMR (200 MHz, CDCl3) δ 10.86 (1H, br s, NHCvS),
7.73–7.07 (12H, m, ArH, 2 × NH), 6.89–6.38 (1H, m, NCH),
6.21–5.84 (1H, m, NCH), 5.25–4.93 (1H, m, NCH), 4.32–4.01
(1H, m, NCH), 3.28–2.67 (4H, m, CH2CO2tBu, NCH2),
2.47–1.65 (5H, m, 4 × CHH, NH), 1.43 [9H, s, C(CH3)3], 1.39
[9H, s, C(CH3)3];
13C NMR (50 MHz, CDCl3) δ 205.7 (CvS),
181.5 (NHCvSNH), 170.2 (CO), 169.8 (CO), 137.9 (Ar), 136.9
(Ar), 128.7 (Ar), 128.5 (Ar), 128.1 (Ar), 127.8 (Ar), 82.5
[C(CH3)3], 81.9 [C(CH3)3], 67.9 (NCH), 63.2 (NCH), 62.8
(NCH), 54.1 (NCH), 47.2 (NCH2), 38.0 (CH2CO2tBu), 29.7
(CH2), 28.0 [C(CH3)3], 27.9 [C(CH3)3], 25.8 (CH2); MS
(ESI) 623 (M + H+, 100%); HRMS exact mass calculated for
[M + H]+ (C32H45O4N4S2) requires m/z 613.2877, found m/z
613.2874.
(S)-N-((1S,2S)-2-(3-(3,5-bis(triﬂuoromethyl)phenyl)thioureido)-
1,2-diphenylethyl)-1-((S)-pyrrolidine-2-carbonyl)pyrrolidine-2-
carboxamide (12). Light yellow solid; 0.07 g, 100% yield; mp
149–151 °C; [α]D = −45.1 (c = 1.0, CH3OH); 1H NMR
(200 MHz, CD3OD) δ 8.24–8.13 (2H, m, 2 × ArH), 7.66–7.59
(1H, m, ArH), 7.36–7.08 (10H, m, ArH), 6.16 (1H, d, J = 9.6
Hz, NCH), 5.40 (1H, d, J = 9.6 Hz, NCH), 4.56–4.41 (1H, m,
NCH), 4.00–3.84 (1H, m, NCH), 3.65–3.44 (2H, m, NCH2),
3.14–2.63 (2H, m, NCH2), 2.33–1.53 (8H, m, 8 × CHH);
13C
NMR (50 MHz, CD3OD) δ 182.6 (CvS), 174.1 (173.9) (CO),
172.9 (172.8) (CO), 143.0 (Ar), 140.0 (Ar), 139.7 (Ar), 132.7
(q, J = 33.1 Hz, Ar), 129.6 (Ar), 129.5 (Ar), 129.1 (Ar), 128.9
(Ar), 128.7 (Ar), 128.6 (Ar), 124.7 (q, J = 272.3 Hz, CF3),
123.5 (Ar), 117.9 (Ar), 63.9 (NCH), 61.7 (NCH), 60.0 (NCH),
59.8 (NCH), 48.2 (NCH2), 48.0 (NCH2), 30.7 (CH2), 30.4
(CH2), 26.7 (CH2), 25.8 (CH2); MS (ESI) 678 (M + H
+, 100%);
HRMS exact mass calculated for [M + H]+ (C33H34F6O2N5S)
requires m/z 678.2332, found m/z 678.2322.
(S)-Di-tert-butyl 2-(3-((1S,2S)-1,2-diphenyl-2-((S)-pyrrolidine-
2-carbonyloxy) ethyl)thioureido)succinate (13). White solid;
0.07 g, 95% yield; mp 60–62 °C; [α]D = +16.4 (c = 1.0, CHCl3);
IR (ﬁlm) 3347, 2916, 2848, 1732, 1556, 1219, 1152, 772 cm−1;
1H NMR (200 MHz, CDCl3) δ 7.43–6.88 (12H, m, ArH,
2 × NH), 6.19–6.01 (1H, m, NCH), 5.26–5.04 (1H, m, OCH),
3.88–3.68 (1H, m, NCH), 3.18–2.74 (5H, m, CH2CO, NCH2
and NCH), 2.25–2.01 (1H, m, CHH), 1.99–1.57 (4H, m,
3 × CHH and NH), 1.40 [9H, s, C(CH3)3], 1.35 [9H, s, C
(CH3)3];
13C NMR (50 MHz, CDCl3) δ 182.2 (CvS), 174.8
(174.5) (CO), 170.6 (CO), 170.0 (169.7) (CO), 137.6 (Ar),
136.4 (Ar), 128.3 (Ar), 128.2 (Ar), 127.7 (Ar), 127.4 (Ar), 127.2
(Ar), 126.9 (Ar), 82.2 [C(CH3)3], 81.2 [C(CH3)3], 78.1 (77.2)
(OCH), 62.3 (NCH), 59.7 (NCH), 54.2 (NCH), 46.7 (NCH2),
37.6 (CH2CO), 30.0 (CH2), 28.0 [C(CH3)3], 27.8 [C(CH3)3],
25.2 (CH2); MS (ESI) 598 (M + H
+, 100%); HRMS exact mass
calculated for [M + H]+ (C32H44O6N3S) requires m/z 598.2945,
found m/z 598.2927.
(S)-2-[(1S,2S)-2-3,5-Bis(triﬂuoromethyl)phenylcarbamothio-
yloxy]-1,2-diphenylethylcarbamoyl) pyrrolidinium 2,2,2-
triﬂuoroacetate (14). White solid; 0.11 g, 91% yield; mp
97–99 °C; [α]D = −9.3 (c = 1.0, CHCl3); IR (ﬁlm) 3238, 2917,
2849, 1735, 1672, 1563, 1379, 1218, 1180, 1136, 772 cm−1; 1H
NMR (200 MHz, CD3OD) δ 8.18–8.01 (2H, m, ArH),
7.74–6.96 (13H, m, 11 × ArH, 2 × NH), 6.32 (0.6H, d, J =
12 Hz, OCH), 6.14 (0.4H, dd, J = 7.2 Hz and 4.0 Hz, OCH),
4.58–4.46 (0.5H, m, NCH), 4.44–4.26 (0.5H, m, NCH),
4.21–3.98 (1H, m, NCH), 3.31–3.06 (2H, m, NCH2), 2.57–1.63
(6H, m, 4 × CHH, 2 × NH); 13C NMR (50 MHz, CD3OD) δ
188.5 (CvS), 168.4 (q, J = 15.9 Hz, CF3CO2
−) 168.7 (168.2)
(CO), 142.8 (143.5) (Ar), 142.2 (142.5) (Ar), 141.7 (141.8)
(Ar), 133.2 (q, J = 33.2 Hz, Ar), 130.2 (Ar), 129.6 (Ar), 129.2
(Ar), 129.1 (Ar), 128.1(Ar), 127.4 (Ar), 124.5 (q, J = 272.1 Hz,
CF3), 119.8 (Ar), 117.4 (Ar), 114.9 (q, J = 243.9 Hz, CF3), 76.9
(80.7) (OCH), 60.7 (m, NCH), 57.9 (58.6) (m, NCH), 47.2
(m, NCH2), 30.6 (m, CH2), 24.5 (m, CH2); MS (ESI) 582
(M + H+, 100%); HRMS exact mass calculated for [M + H]+
(C28H26F6O2N3S) requires m/z 582.1644, found m/z 582.1626.
(S)-N-((1S,2S)-1,2-Diphenyl-2-(3-phenylthioureido) ethyl)
pyrrolidine-2-carboxamide (15). White solid; 0.05 g, 100%
yield; mp 85–88 °C; [α]D = −25.8 (c = 1.0, CHCl3); IR (ﬁlm)
3303, 2916, 2849, 1735, 1665, 1540, 1465, 1218, 772 cm−1; 1H
NMR (200 MHz, CDCl3) δ 9.04 (1H, s, NH), 8.63 (1H, d, J =
9.4 Hz, NH), 7.86 (1H, d, J = 8.8 Hz, ArH), 7.56–6.15 (15H, m,
14 × ArH and NH), 6.07 (1H, t, J = 9.0 Hz, NCH), 5.29 (1H, t,
J = 9.8 Hz, NCH), 3.67 (1H, dd, J = 4.2 Hz, J = 6.2 Hz, NCH),
3.15–2.63 (3H, m, NCH2, NH), 2.16–1.35 (4H, m, 4 × CHH);
13C NMR (50 MHz, CDCl3) δ 180.8 (CvS), 175.0 (CO), 137.9
(Ar), 137.4 (Ar), 129.1 (Ar), 128.4 (Ar), 128.2 (Ar), 127.5 (Ar),
127.4 (Ar), 127.3 (Ar), 125.9 (Ar), 124.3 (Ar), 63.3 (NCH),
60.2 (NCH), 58.8 (NCH), 46.6 (NCH2), 29.9 (CH2), 25.4 (CH2);
MS (ESI) 445 (M + H+, 100%); HRMS exact mass calculated
for [M + H]+ (C26H29ON4S) requires m/z 445.2057, found m/z
445.2038.
(S)-N-((1S,2S)-2-(3-Methyl-3-phenylthioureido)-1,2-diphenyl-
ethyl)pyrrolidine-2-carboxamide (16). White solid; 0.06 g,
100% yield; mp 55–57 °C; [α]D = −112.5 (c = 1.0, CHCl3); IR
(ﬁlm) 3248, 2916, 2848, 1735, 1651, 1515, 1465, 1218,
772 cm−1; 1H NMR (200 MHz, CDCl3) δ 8.38 (1H, d, J = 9.0
Hz, NH), 7.62–7.39 (3H, m, ArH), 7.38–6.89 (9H, m, ArH),
6.88–6.69 (3H, m, ArH), 6.48 (1H, d, J = 8.0 Hz, NH), 5.87
(1H, t, J = 8.8 Hz, NCH), 4.99 (1H, t, J = 9.2 Hz, NCH),
3.83–3.35 (4H, m, NCH3, NCH), 3.02–2.57 (3H, m, NCH2,
NH), 2.16–1.91 (1H, m, CHH), 1.79–1.38 (3H, m, 3 × CHH);
13C NMR (50 MHz, CDCl3) δ 181.5 (CvS), 174.8 (CO), 142.6
(Ar), 138.7 (Ar), 138.2 (Ar), 130.4 (Ar), 128.5 (Ar), 128.3 (Ar),
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128.2 (Ar), 128.0 (Ar), 127.4 (Ar), 127.3 (Ar), 126.9 (Ar), 64.3
(NCH), 60.3 (NCH), 58.0 (NCH), 47.0 (NCH2), 43.2 (NCH3),
30.3 (CH2), 25.8 (CH2); MS (ESI) 459 (M + H
+, 100%); HRMS
exact mass calculated for [M + H]+ (C27H31ON4S) requires m/z
459.2213, found m/z 459.2196.
General procedure for the aldol reaction
To a stirring solution of catalyst 8 (8 g, 0.014 mol) in toluene
(1.0 mL), 4-nitrobenzoic acid (2.5 g, 0.014 mol) was added.
Aldehyde (0.14 mol) followed by ketone (1.40 mol) were added
at −20 °C. The reaction mixture was left stirring at −20 °C until
the reaction was complete (by TLC). The solvent was evaporated
and the crude product was puriﬁed using ﬂash column chromato-
graphy eluting with various mixtures of petroleum ether
(40–60 °C): EtOAc. All characterization data for the aldol pro-
ducts are in accordance with literature. For full experimental data
of the aldol products, see the ESI.‡
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